From Quiver Quantitative:

Apple is dealing with a major legal hurdle in its battle with Masimo over patents, as a US court has refused to extend a pause on the import ban of certain Apple Watch models. The ban covers Apple’s Series 9 and Ultra 2 smartwatches, which include a blood oxygen measurement feature that Masimo claims infringes upon its patents. Apple is now forced to stop selling these models in the US while the legal battle continues, a process that could take over a year. However, the company has developed a software workaround that allows it to sell redesigned watches without the disputed feature. Meanwhile, Masimo’s shares have risen as much as 2.8% following the court’s decision. The ban could potentially affect Apple’s competitiveness in the US smartwatch market and impact the company’s revenue. Apple has not yet commented on this latest development.



Read more: Masimo’s Patent Win Stirs Apple Watch Market Disruption